Prospective study of Centurion® versus Infiniti® phacoemulsification systems: surgical and visual outcomes

• DOI: 10.18240/ijo.2017.11.10
• Publication Date: 2017-11-09T03:01:45Z
• Authors: Lawrence Oh; Chu Luan Nguyen; Eugene Wong; Samuel Sherng You...; Ian C. Francis
• Keywords: 3212 Ophthalmology and Optometry; Centurion; visual and surgical outcomes; 610; 32 Biomedical and Clinical Sciences; RE1-994; 3. Good health; Ophthalmology; 03 medical and health sciences; anzsrc-for: 32 Biomedical and Clinical Sciences; 0302 clinical medicine; Clinical Research; anzsrc-for: 3212 Ophthalmology and Optometry; anzsrc-for: 1113 Opthalmology and Optometry; 616; phacoemulsification; 1702; Infiniti; cumulated dissipated energy; Eye Disease and Disorders of Vision

AIM: To evaluate surgical outcomes (SOs) and visual (VOs) in cataract surgery comparing the Centurion® phacoemulsification system (CPS) with Infiniti® (IPS). METHODS: Prospective, consecutive study a single-site private practice. Totally 412 patients undergoing either CPS using 30-degree balanced® tip (n=207) or IPS Kelman® (n=205). Intraoperative postoperative were documented prospectively up to one month follow-up. Nuclear sclerosis (NS) grade, cumulated dissipated energy (CDE), preoperative corrected distance acuity (CDVA), CDVA at recorded. RESULTS: CDE was 13.50% less whole compared subcohort. In eyes NS grade III greater, 28.87% (n=70) (n=44) (P=0.010). Surgical complications not statistically different between two subcohorts (P=0.083), but case of vitreous loss CPS, 6/4 achieved month. The mean CDVAs for above cataracts -0.17 logMAR (6/4.5) -0.15 subcohort respectively (P=0.033). CONCLUSION: is less, VOs are significantly improved, denser IPS. authors recommend cases nuclei.